— Treatment of nasopharyngeal carcinoma is done by advanced radiotherapy techniques like VMAT (Volumetric Modulated Arc Therapy) where dose to critical organs around tumour is of concern. Present study aimed to describe radiation dose to critical organs in nasopharyngeal cancer patients using VMAT technique. Study was conducted on 10 carcinoma nasopharynx patients treated by VMAT technique at a super-specialty cancer institute in Rajasthan. The structures were contoured using RTOG (Radiation Therapy Oncology Group) guidelines and dose prescription to PTV (Planning Target Volume) was such that 95% iso-dose covered 100% of PTV. Constraints to the OARs (Organs at risk) were as per QUANTEC (Quantitative Analysis of Normal Tissue Effects in the Clinic). VMAT planning was done by double arc using Eclipse (v 10.0.42) treatment planning system. Mean dose to brain stem, spinal cord and optic chiasma were 51.79 Gy, 45.92 Gy and 18.8 Gy respectively. Mean dose to left and right temporal lobes was 22.7Gy and 24.3Gy. Dose to right and left eye were 20.6 Gy and 19.2 Gy while dose to right and left lenses were 5.9Gy and 5.8 Gy respectively. Dose to brain stem, spinal cord, optic chiasma, eyes, lens and temporal lobes were below the dose constraints. VMAT is an effective way to deliver maximum radiation to tumour tissue while providing better sparing of normal tissue and less doses to OARs in carcinoma nasopharynx.
ROSE CASE - SRS/ STEREOTACTIC RADIOTHERAPY FOR MENINGIOAMAKanhu Charan
The document describes a case of stereotactic radiosurgery treatment planning for a 41-year-old female patient with a petroclival meningioma. It details her history, imaging findings showing a 2.2x1.9x2.3cm lesion, pathology confirming a grade 1 transitional meningioma, and prior near total excision. A multidisciplinary tumor board decided on stereotactic radiotherapy. Simulation imaging with MRI and CT was performed and the gross tumor volume, planning target volume, and organs at risk were delineated. A dose of 25Gy in 5 fractions was selected and treatment planning was done to meet coverage and organ at risk constraints.
Topic of the month.... The role of gamma knife in the management of brain met...Professor Yasser Metwally
Metastatic disease to the brain occurs in a significant percentage of cancer patients and limits survival. Traditionally, whole-brain radiation therapy and glucocorticoids were used to treat brain metastases, while surgery was used for localized tumors. Recently, stereotactic radiosurgery has emerged as a less invasive alternative for local tumor treatment. Studies have shown stereotactic radiosurgery improves local tumor control and survival when combined with whole-brain radiation therapy, especially for patients with a single metastasis or up to three metastases. Stereotactic radiosurgery provides precise, high doses of radiation to tumor targets using specialized equipment and imaging for guidance and treatment planning.
1) Brain metastases are the most common intracranial tumors in adults, developing in 10-30% of patients with cancer.
2) Primary tumors that commonly metastasize to the brain include lung cancer, breast cancer, kidney cancer, and colorectal cancer in adults and sarcomas, neuroblastoma, and germ cell tumors in children.
3) Treatment for brain metastases depends on the patient's health status, primary tumor type, and number/location of lesions, and may include corticosteroids, whole brain radiation, surgery, stereotactic radiosurgery, or a combination of these approaches tailored to the individual patient.
Step-by-Step Stereotactic Radiotherapy Planning of Vestibular Schwannoma: A G...Kanhu Charan
This document provides a step-by-step guide to stereotactic radiotherapy planning for vestibular schwannoma. It describes the case of a 40-year-old male patient presenting with symptoms of tinnitus, dizziness, and facial twitching. Imaging including CT and MRI confirmed a right-sided vestibular schwannoma. The tumor was graded and treatment options were discussed. The patient was planned for fractionated stereotactic radiotherapy to a dose of 25Gy in 5 fractions based on guidelines. The planning process is then described in detail, including CT simulation, MRI protocol, contouring of targets and organs at risk, plan evaluation criteria, and subsequent treatment.
This study evaluated outcomes of 28 patients with intracranial meningiomas treated with hypofractionated radiosurgery. Most tumors were treated with 22.5-30 Gy delivered in 5 fractions. With a mean follow up of 32.6 months, the local tumor control rate was 100% with only one instance of marginal progression. Symptoms improved or resolved in over 66% of patients who originally presented with symptoms. Side effects occurred in 4 patients but the permanent morbidity rate was low at 3.5%. Hypofractionated radiosurgery provided high tumor control with a low risk of side effects, even for large tumors greater than 9 cm3.
Stereotactic radiosurgery (SRS) is a non-invasive technique that uses precisely targeted radiation to treat tumors and abnormalities in the brain. It can deliver high doses of radiation to tumors while minimizing damage to surrounding healthy tissue. SRS uses stereotactic guidance systems and imaging to pinpoint tumors for radiation targeting in fewer treatments than traditional therapy. Common applications of SRS include treatment of brain metastases, acoustic neuromas, meningiomas, arteriovenous malformations, and pituitary tumors. Control rates for these indications are high, often over 90% depending on factors like tumor size and location.
Efficacy Of Imrt Through Dmlc And Inverse Planningfondas vakalis
1) The document discusses using intensity modulated radiation therapy (IMRT) with dynamic multileaf collimator (DMLC) and inverse planning for various cancer types including nasopharyngeal carcinoma (NPC), prostate cancer, lung cancer and others.
2) Preliminary results showed IMRT achieved better dose conformity to the target, reduced doses to nearby critical organs, and improved target dose uniformity compared to conventional techniques.
3) For diseases like NPC where the target has a concave shape, IMRT was able to spare more of the spinal cord and parotid glands while maintaining a uniform high dose to the target.
Stereotactic radiosurgery (SRS) uses precisely targeted beams of radiation from multiple angles to treat brain tumors with minimal damage to surrounding tissue. It can be delivered via linear accelerator, Gamma Knife, or Cyberknife. SRS provides high tumor control rates for both benign and malignant brain tumors with relatively low risk of side effects. While SRS alone may be sufficient to treat a limited number of brain metastases, whole brain radiation is often added to improve control of additional metastases. Neurosurgeons play an important role in patient selection and treatment planning for SRS.
ROSE CASE - SRS/ STEREOTACTIC RADIOTHERAPY FOR MENINGIOAMAKanhu Charan
The document describes a case of stereotactic radiosurgery treatment planning for a 41-year-old female patient with a petroclival meningioma. It details her history, imaging findings showing a 2.2x1.9x2.3cm lesion, pathology confirming a grade 1 transitional meningioma, and prior near total excision. A multidisciplinary tumor board decided on stereotactic radiotherapy. Simulation imaging with MRI and CT was performed and the gross tumor volume, planning target volume, and organs at risk were delineated. A dose of 25Gy in 5 fractions was selected and treatment planning was done to meet coverage and organ at risk constraints.
Topic of the month.... The role of gamma knife in the management of brain met...Professor Yasser Metwally
Metastatic disease to the brain occurs in a significant percentage of cancer patients and limits survival. Traditionally, whole-brain radiation therapy and glucocorticoids were used to treat brain metastases, while surgery was used for localized tumors. Recently, stereotactic radiosurgery has emerged as a less invasive alternative for local tumor treatment. Studies have shown stereotactic radiosurgery improves local tumor control and survival when combined with whole-brain radiation therapy, especially for patients with a single metastasis or up to three metastases. Stereotactic radiosurgery provides precise, high doses of radiation to tumor targets using specialized equipment and imaging for guidance and treatment planning.
1) Brain metastases are the most common intracranial tumors in adults, developing in 10-30% of patients with cancer.
2) Primary tumors that commonly metastasize to the brain include lung cancer, breast cancer, kidney cancer, and colorectal cancer in adults and sarcomas, neuroblastoma, and germ cell tumors in children.
3) Treatment for brain metastases depends on the patient's health status, primary tumor type, and number/location of lesions, and may include corticosteroids, whole brain radiation, surgery, stereotactic radiosurgery, or a combination of these approaches tailored to the individual patient.
Step-by-Step Stereotactic Radiotherapy Planning of Vestibular Schwannoma: A G...Kanhu Charan
This document provides a step-by-step guide to stereotactic radiotherapy planning for vestibular schwannoma. It describes the case of a 40-year-old male patient presenting with symptoms of tinnitus, dizziness, and facial twitching. Imaging including CT and MRI confirmed a right-sided vestibular schwannoma. The tumor was graded and treatment options were discussed. The patient was planned for fractionated stereotactic radiotherapy to a dose of 25Gy in 5 fractions based on guidelines. The planning process is then described in detail, including CT simulation, MRI protocol, contouring of targets and organs at risk, plan evaluation criteria, and subsequent treatment.
This study evaluated outcomes of 28 patients with intracranial meningiomas treated with hypofractionated radiosurgery. Most tumors were treated with 22.5-30 Gy delivered in 5 fractions. With a mean follow up of 32.6 months, the local tumor control rate was 100% with only one instance of marginal progression. Symptoms improved or resolved in over 66% of patients who originally presented with symptoms. Side effects occurred in 4 patients but the permanent morbidity rate was low at 3.5%. Hypofractionated radiosurgery provided high tumor control with a low risk of side effects, even for large tumors greater than 9 cm3.
Stereotactic radiosurgery (SRS) is a non-invasive technique that uses precisely targeted radiation to treat tumors and abnormalities in the brain. It can deliver high doses of radiation to tumors while minimizing damage to surrounding healthy tissue. SRS uses stereotactic guidance systems and imaging to pinpoint tumors for radiation targeting in fewer treatments than traditional therapy. Common applications of SRS include treatment of brain metastases, acoustic neuromas, meningiomas, arteriovenous malformations, and pituitary tumors. Control rates for these indications are high, often over 90% depending on factors like tumor size and location.
Efficacy Of Imrt Through Dmlc And Inverse Planningfondas vakalis
1) The document discusses using intensity modulated radiation therapy (IMRT) with dynamic multileaf collimator (DMLC) and inverse planning for various cancer types including nasopharyngeal carcinoma (NPC), prostate cancer, lung cancer and others.
2) Preliminary results showed IMRT achieved better dose conformity to the target, reduced doses to nearby critical organs, and improved target dose uniformity compared to conventional techniques.
3) For diseases like NPC where the target has a concave shape, IMRT was able to spare more of the spinal cord and parotid glands while maintaining a uniform high dose to the target.
Stereotactic radiosurgery (SRS) uses precisely targeted beams of radiation from multiple angles to treat brain tumors with minimal damage to surrounding tissue. It can be delivered via linear accelerator, Gamma Knife, or Cyberknife. SRS provides high tumor control rates for both benign and malignant brain tumors with relatively low risk of side effects. While SRS alone may be sufficient to treat a limited number of brain metastases, whole brain radiation is often added to improve control of additional metastases. Neurosurgeons play an important role in patient selection and treatment planning for SRS.
Stereotactic Radiosurgery and Radiotherapy of Brain Metastases Clinical White...Brainlab
This document summarizes the treatment of brain metastases using stereotactic radiosurgery (SRS) and radiotherapy (SRT). It notes that brain metastases are common in cancer patients and often fatal. While whole brain radiotherapy was previously standard, it causes long-term neurotoxicity. SRS allows high radiation doses to targeted lesions with reduced toxicity. Studies show SRS and SRT achieve high tumor control rates of 47-80% at one year with overall survival of 9-17 months and low toxicity, establishing them as preferred treatments for brain metastases.
Cancer of Right Breast with Single Liver Metastasis - Simultaneous Treatment ...Kanhu Charan
Cancer of Right Breast with Single Liver Metastasis - Simultaneous
Treatment of Chest Wall with Radiotherapy for Carcinoma Breast and
SBRT for Liver Lesion - Procedural Details of the Complex Procedure
Radical brachytherapy for early stage external auditory canalKanhu Charan
1) Early stage squamous cell carcinoma of the external ear canal is rare and current treatment options like surgery can result in poor cosmesis or loss of function. 2) Brachytherapy provides a high dose to the target area while sparing surrounding organs but traditional applicators are costly. 3) The author proposes using a simple plastic earbud as a low-cost applicator for brachytherapy of the external ear canal. Dosimetry studies showed the earbud dimensions are comparable to catheter applicators and it can be stabilized using a stethoscope earpiece, providing a reproducible method of brachytherapy.
01 suh brain anatomy, planning and delivery hyderabad 2013 (cancer ci 2013) j...Dr. Vijay Anand P. Reddy
This document provides an overview of brain anatomy, advances in radiation therapy treatment planning and delivery for brain tumors, and methods to focus radiation dose on tumors while minimizing dose to healthy brain tissue. It discusses contouring important brain structures, use of imaging like CT and MRI in treatment planning, and the evolution of techniques like intensity modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT). It also reviews stereotactic radiosurgery and different technologies used like Gamma Knife and linear accelerators. The document concludes that understanding brain anatomy and dose constraints is essential for optimizing radiation delivery for brain tumors.
Protons Compared to Photons in Pediatric PatientsDanielle Buswell
Proton radiation therapy may reduce risks of late side effects compared to photon therapy for pediatric patients with medulloblastoma. Proton therapy decreases exit dose which can cause toxicities like heart problems, hearing loss, and neurocognitive deficits. Studies found proton therapy resulted in fewer neurocognitive deficits and lower risks of secondary cancers. While proton therapy may have better outcomes, its higher cost must be considered compared to photon therapy for each patient.
Cancer of Right Breast with Single-Liver MetastasisSimultaneous Treatment of ...Kanhu Charan
Cancer of Right Breast with Single-Liver Metastasis Simultaneous Treatment of Chest Wall with Radiotherapy for Carcinoma Breast and SBRT for Liver Lesion: Procedural
Details of the Complex Procedure
This document discusses the approach towards re-irradiation of common cancers. It begins by noting that local recurrence after radiation therapy and second primary tumors in irradiated areas are challenges, though re-irradiation can provide durable disease control in some cases. It then discusses key considerations for re-irradiation of head and neck cancers, gliomas, gynecological cancers, bone metastases, and brain metastases. Important factors include the initial radiation dose, interval since prior radiation, intent of re-irradiation, cumulative organ doses, and risk versus benefit. Advanced radiation techniques like IMRT can help minimize toxicity risks from re-irradiation. Careful patient selection and multidisciplinary evaluation are emphasized for meaningful survival benefits from re-
This document discusses simulation techniques and tips for pancreatic malignancy radiosurgery. It covers the workflow from planning to delivery and various techniques for motion management including gating, tracking, abdominal compression and breath holds. Imaging protocols including triple phase CT and PET scans are described for target and organ at risk visualization. Steps for patient preparation, positioning, immobilization and counseling are also outlined.
HOLISTIC APPROACH IN WHOLE BRAIN RADIATION IN BRAIN METSKanhu Charan
1. Whole brain radiotherapy is commonly used to treat brain metastases but can cause long-term side effects like memory loss and decreased quality of life.
2. A new study aims to spare structures like the hippocampus, cochlea, and parotid glands using IMRT and VMAT to reduce side effects while maintaining tumor coverage.
3. Dosimetry results found that IMRT and VMAT reduced hippocampal, parotid, and cochlear doses by 45-82% compared to conventional radiotherapy, allowing for improved quality of life.
1) The document discusses the case of a 38-year-old Hindu male patient from Visakhapatnam presenting with a 2x1cm ulcer on the right lateral border of his tongue.
2) It describes his medical history including a history of ill-fitting dentures and dying during an MRI evaluation due to an allergic reaction to contrast.
3) The oncologist discusses potential treatment options with the patient including radiation therapy to preserve his tongue and avoid surgery, as well as interviews with ENT specialists and a dentist.
Adjuvant Radiation Therapy in Early Cervical Cancer - EvidencesDr. Malhar Patel
Radiation therapy is one of the main line of management of carcinoma cervix.
This presentation is regarding evidences of adjuvant radiation therapy (post operative) in case of early carcinoma cervix.
Stereotactic Radiotherapy for the Treatment of Acoustic Neuromas Clinical Whi...Brainlab
Learn more: https://www.brainlab.com/radiosurgery-products/
Acoustic neuromas (AN) have an annual incidence of approximately one per 100,000 people and may account for up to 8% of all new tumors presenting to a neurosurgical referral practice. Acoustic neuromas are benign tumors arising from Schwann cells from the vestibular branch of the eighth cranial nerve. Nevertheless, they can pursue a potentially aggressive course, with uncontrolled local growth resulting in compression of the brainstem and fourth ventricle, cranial nerve and other neurological deficits.
Brain metastasis is a common complication of systemic cancers. Stereotactic radiosurgery (SRS) is an effective treatment modality for patients with a limited number of brain metastases and good performance status. SRS provides high local tumor control rates comparable to surgery but is non-invasive. While SRS alone risks new metastases developing elsewhere in the brain, combining SRS with whole brain radiation therapy improves local and distant brain control but increases risks of cognitive decline. Patient prognosis depends on factors like performance status, number and size of metastases, and control of the primary cancer.
Management of brain metastases ver final by dr manas dubey 6 07-2019Dr Manas Dubey
Management of Brain metastases involves treating the symptoms, determining the primary cancer, and selecting the optimal treatment strategy. Treatment options include surgery, whole brain radiation therapy (WBRT), and stereotactic radiosurgery (SRS). For a single metastasis, surgery plus WBRT provides the best tumor control and survival rates. For multiple metastases, WBRT is often used initially but SRS can be added as a boost. Oligometastatic patients with 1-3 lesions may benefit from upfront WBRT combined with SRS.
The document discusses treatment options for brain metastases including surgery, whole brain radiation therapy (WBRT), and stereotactic radiosurgery (SRS). It notes that while WBRT was traditionally used, studies show SRS alone may be preferred for limited brain metastases to avoid cognitive decline risks from WBRT. For larger or multiple tumors, WBRT provides better local and distant tumor control compared to SRS alone. Ongoing research evaluates hippocampal-sparing WBRT and the role of SRS boost after surgery to improve outcomes while preserving cognition. The optimal approach depends on disease factors and emerging evidence favors SRS for limited metastases to balance survival benefits with quality of life.
This document provides guidance on the medical management of brain metastases. It discusses diagnostic evaluation with MRI, prognostic classification using RPA, and treatment approaches based on prognosis. For a patient with multiple hemorrhagic lung cancer brain metastases undergoing metastasectomy, it recommends continuing dexamethasone for edema, discontinuing anticoagulation given surgery, and not using antiepileptics without a seizure history. Neurology input is suggested regarding antiepileptic use.
Description of Different Phases of Brain Tumor Classificationasclepiuspdfs
The proposed approach makes contributions in various stages in the development of a computer-aided diagnosis (CAD) system of brain diseases, namely image preprocessing, intermediate processing, detection, segmentation, feature extraction, and classification. Literature study incorporates many important ideas for abnormalities detection and analysis with their advantages and disadvantages. Literature studies have pointed out the needs of dividing task and appropriate ways for accurate abnormality characterization to provide a proper clinical diagnosis.
This document contains abstracts from several studies related to head and neck cancers. The first abstract compares outcomes of 3D conformal radiotherapy versus cobalt-60 teletherapy for larynx cancer. It found no significant differences in overall survival or local control between the two techniques, but acute reactions differed significantly. The second abstract finds that simultaneous integrated boost IMRT may be superior to sequential IMRT for nasopharyngeal cancer in reducing dose to organs at risk and toxicity. The third explores whether neck irradiation can replace neck dissection for stage 1 tongue cancer patients, finding no significant difference in disease-free survival between the two groups.
This document discusses craniospinal irradiation (CSI) techniques. It defines CSI as radiation delivered to the entire cranial-spinal axis. The document outlines the indications for CSI including various types of brain tumors. It then discusses the challenges of CSI due to the large irregular target volume and proximity to critical structures. The document focuses on the 3D conformal technique in supine position used at the author's department. It describes patient positioning, immobilization, simulation, target and organ at risk delineation, and treatment planning. Complications of CSI and the role of chemotherapy are also reviewed. Alternative CSI techniques like IMRT and proton therapy are mentioned but have limitations. Dosimetric studies find modern
Stereotactic Radiosurgery and Radiotherapy of Brain Metastases Clinical White...Brainlab
This document summarizes the treatment of brain metastases using stereotactic radiosurgery (SRS) and radiotherapy (SRT). It notes that brain metastases are common in cancer patients and often fatal. While whole brain radiotherapy was previously standard, it causes long-term neurotoxicity. SRS allows high radiation doses to targeted lesions with reduced toxicity. Studies show SRS and SRT achieve high tumor control rates of 47-80% at one year with overall survival of 9-17 months and low toxicity, establishing them as preferred treatments for brain metastases.
Cancer of Right Breast with Single Liver Metastasis - Simultaneous Treatment ...Kanhu Charan
Cancer of Right Breast with Single Liver Metastasis - Simultaneous
Treatment of Chest Wall with Radiotherapy for Carcinoma Breast and
SBRT for Liver Lesion - Procedural Details of the Complex Procedure
Radical brachytherapy for early stage external auditory canalKanhu Charan
1) Early stage squamous cell carcinoma of the external ear canal is rare and current treatment options like surgery can result in poor cosmesis or loss of function. 2) Brachytherapy provides a high dose to the target area while sparing surrounding organs but traditional applicators are costly. 3) The author proposes using a simple plastic earbud as a low-cost applicator for brachytherapy of the external ear canal. Dosimetry studies showed the earbud dimensions are comparable to catheter applicators and it can be stabilized using a stethoscope earpiece, providing a reproducible method of brachytherapy.
01 suh brain anatomy, planning and delivery hyderabad 2013 (cancer ci 2013) j...Dr. Vijay Anand P. Reddy
This document provides an overview of brain anatomy, advances in radiation therapy treatment planning and delivery for brain tumors, and methods to focus radiation dose on tumors while minimizing dose to healthy brain tissue. It discusses contouring important brain structures, use of imaging like CT and MRI in treatment planning, and the evolution of techniques like intensity modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT). It also reviews stereotactic radiosurgery and different technologies used like Gamma Knife and linear accelerators. The document concludes that understanding brain anatomy and dose constraints is essential for optimizing radiation delivery for brain tumors.
Protons Compared to Photons in Pediatric PatientsDanielle Buswell
Proton radiation therapy may reduce risks of late side effects compared to photon therapy for pediatric patients with medulloblastoma. Proton therapy decreases exit dose which can cause toxicities like heart problems, hearing loss, and neurocognitive deficits. Studies found proton therapy resulted in fewer neurocognitive deficits and lower risks of secondary cancers. While proton therapy may have better outcomes, its higher cost must be considered compared to photon therapy for each patient.
Cancer of Right Breast with Single-Liver MetastasisSimultaneous Treatment of ...Kanhu Charan
Cancer of Right Breast with Single-Liver Metastasis Simultaneous Treatment of Chest Wall with Radiotherapy for Carcinoma Breast and SBRT for Liver Lesion: Procedural
Details of the Complex Procedure
This document discusses the approach towards re-irradiation of common cancers. It begins by noting that local recurrence after radiation therapy and second primary tumors in irradiated areas are challenges, though re-irradiation can provide durable disease control in some cases. It then discusses key considerations for re-irradiation of head and neck cancers, gliomas, gynecological cancers, bone metastases, and brain metastases. Important factors include the initial radiation dose, interval since prior radiation, intent of re-irradiation, cumulative organ doses, and risk versus benefit. Advanced radiation techniques like IMRT can help minimize toxicity risks from re-irradiation. Careful patient selection and multidisciplinary evaluation are emphasized for meaningful survival benefits from re-
This document discusses simulation techniques and tips for pancreatic malignancy radiosurgery. It covers the workflow from planning to delivery and various techniques for motion management including gating, tracking, abdominal compression and breath holds. Imaging protocols including triple phase CT and PET scans are described for target and organ at risk visualization. Steps for patient preparation, positioning, immobilization and counseling are also outlined.
HOLISTIC APPROACH IN WHOLE BRAIN RADIATION IN BRAIN METSKanhu Charan
1. Whole brain radiotherapy is commonly used to treat brain metastases but can cause long-term side effects like memory loss and decreased quality of life.
2. A new study aims to spare structures like the hippocampus, cochlea, and parotid glands using IMRT and VMAT to reduce side effects while maintaining tumor coverage.
3. Dosimetry results found that IMRT and VMAT reduced hippocampal, parotid, and cochlear doses by 45-82% compared to conventional radiotherapy, allowing for improved quality of life.
1) The document discusses the case of a 38-year-old Hindu male patient from Visakhapatnam presenting with a 2x1cm ulcer on the right lateral border of his tongue.
2) It describes his medical history including a history of ill-fitting dentures and dying during an MRI evaluation due to an allergic reaction to contrast.
3) The oncologist discusses potential treatment options with the patient including radiation therapy to preserve his tongue and avoid surgery, as well as interviews with ENT specialists and a dentist.
Adjuvant Radiation Therapy in Early Cervical Cancer - EvidencesDr. Malhar Patel
Radiation therapy is one of the main line of management of carcinoma cervix.
This presentation is regarding evidences of adjuvant radiation therapy (post operative) in case of early carcinoma cervix.
Stereotactic Radiotherapy for the Treatment of Acoustic Neuromas Clinical Whi...Brainlab
Learn more: https://www.brainlab.com/radiosurgery-products/
Acoustic neuromas (AN) have an annual incidence of approximately one per 100,000 people and may account for up to 8% of all new tumors presenting to a neurosurgical referral practice. Acoustic neuromas are benign tumors arising from Schwann cells from the vestibular branch of the eighth cranial nerve. Nevertheless, they can pursue a potentially aggressive course, with uncontrolled local growth resulting in compression of the brainstem and fourth ventricle, cranial nerve and other neurological deficits.
Brain metastasis is a common complication of systemic cancers. Stereotactic radiosurgery (SRS) is an effective treatment modality for patients with a limited number of brain metastases and good performance status. SRS provides high local tumor control rates comparable to surgery but is non-invasive. While SRS alone risks new metastases developing elsewhere in the brain, combining SRS with whole brain radiation therapy improves local and distant brain control but increases risks of cognitive decline. Patient prognosis depends on factors like performance status, number and size of metastases, and control of the primary cancer.
Management of brain metastases ver final by dr manas dubey 6 07-2019Dr Manas Dubey
Management of Brain metastases involves treating the symptoms, determining the primary cancer, and selecting the optimal treatment strategy. Treatment options include surgery, whole brain radiation therapy (WBRT), and stereotactic radiosurgery (SRS). For a single metastasis, surgery plus WBRT provides the best tumor control and survival rates. For multiple metastases, WBRT is often used initially but SRS can be added as a boost. Oligometastatic patients with 1-3 lesions may benefit from upfront WBRT combined with SRS.
The document discusses treatment options for brain metastases including surgery, whole brain radiation therapy (WBRT), and stereotactic radiosurgery (SRS). It notes that while WBRT was traditionally used, studies show SRS alone may be preferred for limited brain metastases to avoid cognitive decline risks from WBRT. For larger or multiple tumors, WBRT provides better local and distant tumor control compared to SRS alone. Ongoing research evaluates hippocampal-sparing WBRT and the role of SRS boost after surgery to improve outcomes while preserving cognition. The optimal approach depends on disease factors and emerging evidence favors SRS for limited metastases to balance survival benefits with quality of life.
This document provides guidance on the medical management of brain metastases. It discusses diagnostic evaluation with MRI, prognostic classification using RPA, and treatment approaches based on prognosis. For a patient with multiple hemorrhagic lung cancer brain metastases undergoing metastasectomy, it recommends continuing dexamethasone for edema, discontinuing anticoagulation given surgery, and not using antiepileptics without a seizure history. Neurology input is suggested regarding antiepileptic use.
Description of Different Phases of Brain Tumor Classificationasclepiuspdfs
The proposed approach makes contributions in various stages in the development of a computer-aided diagnosis (CAD) system of brain diseases, namely image preprocessing, intermediate processing, detection, segmentation, feature extraction, and classification. Literature study incorporates many important ideas for abnormalities detection and analysis with their advantages and disadvantages. Literature studies have pointed out the needs of dividing task and appropriate ways for accurate abnormality characterization to provide a proper clinical diagnosis.
Description of Different Phases of Brain Tumor Classification
Similar to Dosimetric evaluation of carcinoma nasopharynx using Volumetric Modulated Arc Therapy (VMAT): An institutional experience from Western India
This document contains abstracts from several studies related to head and neck cancers. The first abstract compares outcomes of 3D conformal radiotherapy versus cobalt-60 teletherapy for larynx cancer. It found no significant differences in overall survival or local control between the two techniques, but acute reactions differed significantly. The second abstract finds that simultaneous integrated boost IMRT may be superior to sequential IMRT for nasopharyngeal cancer in reducing dose to organs at risk and toxicity. The third explores whether neck irradiation can replace neck dissection for stage 1 tongue cancer patients, finding no significant difference in disease-free survival between the two groups.
This document discusses craniospinal irradiation (CSI) techniques. It defines CSI as radiation delivered to the entire cranial-spinal axis. The document outlines the indications for CSI including various types of brain tumors. It then discusses the challenges of CSI due to the large irregular target volume and proximity to critical structures. The document focuses on the 3D conformal technique in supine position used at the author's department. It describes patient positioning, immobilization, simulation, target and organ at risk delineation, and treatment planning. Complications of CSI and the role of chemotherapy are also reviewed. Alternative CSI techniques like IMRT and proton therapy are mentioned but have limitations. Dosimetric studies find modern
Intensity-modulated radiotherapy with simultaneous modulated accelerated boos...Enrique Moreno Gonzalez
To present our experience of intensity-modulated radiotherapy (IMRT) with simultaneous modulated accelerated radiotherapy (SMART) boost technique in patients with nasopharyngeal carcinoma (NPC).
Radiation Oncology in 21st Century - Changing the ParadigmsApollo Hospitals
Since its inception radiation therapy has been used as one of
the essential treatment options in the management of malignant and some benign tumors. With better understanding of tumor biology many new molecules have been added to the armamentarium of an oncologist. There is continuous improvement in surgical techniques with more emphasis on minimally invasive, organ- and function-preserving techniques. Neoadjuvant chemotherapy with or without addition of radiation therapy has helped surgeon downsizing the tumor and obtaining clearer margins.
Breast conserving surgery followed by adjuvant radiotherapy is adopted in the early detected cases and mastectomy followed by radiotherapy or chemotherapy in the advanced cases are the general practices.
Stereotactic body radiotherapy (SBRT) delivers high-dose radiation to tumors in a small number of fractions using high precision. For prostate SBRT, the target and organs at risk are contoured on planning CT. A dose of 35-38Gy in 5 fractions is used as primary treatment for low risk prostate cancer. Rigid image guidance and intrafraction monitoring are important to minimize setup errors. ExacTrac X-ray positioning co-registers X-rays with digitally reconstructed radiographs and corrects for rotational and translational deviations, achieving sub-millimeter accuracy. This allows safe dose escalation for prostate SBRT.
1. The document evaluates volumetric modulated arc therapy (VMAT) for craniospinal irradiation (CSI) treatment planning.
2. It aims to standardize and simplify the CSI planning technique while improving dose conformity and homogeneity in the target volume and reducing dose to organs at risk.
3. VMAT plans for 4 patients using 3 isocenters and 2 arcs each achieved good target coverage with a conformity index of 0.99 and homogeneity index of 1.13 on average while sparing organs at risk.
This document discusses high grade gliomas, which include anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic oligoastrocytoma, and glioblastoma multiforme. It describes the epidemiology, clinical features, prognosis, and management of these tumors. The optimal treatment involves maximal safe surgical resection followed by concurrent chemoradiation and adjuvant chemotherapy. Radiotherapy techniques such as 3D conformal radiation therapy and intensity-modulated radiation therapy aim to deliver a dose of 60 Gy to the tumor volume while sparing surrounding normal brain tissue. However, dose escalation above standard doses has not shown a survival benefit.
Adaptive radiotherapy (ART) can improve treatment for head and neck cancer patients. ART involves modifying the treatment plan based on anatomical changes observed during radiation therapy delivery. For head and neck cancer, target volumes and organs at risk often change significantly over the course of treatment due to factors like weight loss or tumor shrinkage. Studies have shown ART can improve dose distribution by reducing dose to organs at risk while maintaining or improving tumor dose coverage. Clinical benefits of ART include improved local tumor control and fewer treatment toxicities. ART is most beneficial for patients experiencing greater anatomical changes, such as those with more advanced tumors or significant weight loss.
The Advantages of Two Dimensional Techniques (2D) in Pituitary Adenoma TreatmentIOSR Journals
The purpose of the study is to evaluate the two dimensional dose distribution techniques in pituitary adenoma patient treatment in order to provide 2D dose coverage to the target volume while sparing organs at risk (OARs). The CT simulator was used to radiograph 300 patients of pituitary adenomas to conform 2D dose distribution planning inside the tumour bed , and its structures were delineated; including gross target volume (GTV), clinical target volume (CTV), and planning target volume (PTV)], as well as organs at risks (OARs) . Dose distribution analysis was edited to provide 2D dose coverage to the target while sparing organs at risk. The main results of the study were, 2D dose distribution plans increases the unnecessary dose to the critical organs according to their geographical location from the pituitary adenoma site, and the present study , concludes that when the tumour dose increases from 45 to 55 Gy there is a linear proportional increment of dose to the organs at risks, and when the dose is about 60 Gy in 2D, the increment of unnecessary dose to temporal lobe is 0.31 Gy, and to eye is0.34Gy, and to optic chiasm is 0.42 Gy respectively .New techniques, which will lessen the unnecessary dose to OARs, needed to be developed .
This document discusses the use of intensity-modulated radiation therapy (IMRT) in the treatment of cervical cancer. It provides an overview of the history and technological advances in radiation therapy for cervical cancer. It then discusses several studies comparing IMRT to conventional radiation therapy, showing benefits of IMRT such as reduced toxicity and ability to escalate dose. The document also considers integrating IMRT and brachytherapy to further optimize treatment.
This study compared different beam arrangements for stereotactic ablative radiation therapy (SABR) treatment planning for early stage lung cancer. Plans using three coplanar and three non-coplanar beam arrangements were created for 10 patients and evaluated based on dosimetric criteria from RTOG 1021. Non-coplanar plans had significantly better conformity for intermediate dose regions but similar target coverage and dose fall-off compared to coplanar plans. A 10-field plan with 6 or more non-coplanar beams best satisfied the RTOG criteria, with only one minor deviation for maximum rib dose. Further investigation is needed to determine if minor deviations should be accepted given increased treatment time for non-cop
This document describes the step-by-step process for planning stereotactic radiotherapy for a brain metastasis case. It involves clinical evaluation, imaging with MRI and PET-CT, target and organ-at-risk delineation on the planning CT fused with MRI, planning with VMAT technique, and evaluation of the plan based on target coverage, organ-at-risk doses and conformity/homogeneity indices. The case presented is of a 70-year old female breast cancer patient with a solitary 2.2 cm left occipital brain metastasis planned to receive a single 18 Gy fraction stereotactic radiosurgery treatment based on her prognosis and age.
This document summarizes recent advances in the management of high grade gliomas. It discusses current guidelines for radiotherapy treatment planning including target volume delineation. It describes the use of concurrent and adjuvant temozolomide with radiation. Response assessment is based on RANO criteria. Advances discussed include the prognostic value of methylation status and results of trials investigating dose-dense chemotherapy schedules and radiosurgery. MRS is shown to help delineate tumor volumes beyond what is seen on standard MRI alone.
The document discusses intensity-modulated radiation therapy (IMRT) for head and neck cancers. It describes how IMRT improves target coverage and sparing of organs-at-risk like the parotid glands compared to conventional radiation therapy. Studies show IMRT reduces the risk of xerostomia and improves quality of life outcomes for patients.
Abstract—Colorectal cancer is leading cancer-related public health problem. This study was conducted to determine the effect of High-Dose-Rate intraluminal brachytherapy (HDR-BT) with or without interstitial brachytherapy during neoadjuvant chemoradiation for locally advanced rectal cancer. This randomized contrial was conducted on 28 patients attended with locally advanced rectal cancer (T3, T4 or N+) treated initially with concurrent capecitabine (800 mg/m2 twice daily for 5 days per week) and pelvic external beam radiation therapy (45Gy in 25 Fractions) after one week MRI for all patients; received intraluminal HDR-BT with 4Gy x 2 Fractions with one week interval for those had gross residual disease within 1cm of rectal wall and receiveed intraluminal and interstitial brachytherapy with 4Gy x 2 Fractions with one week interval for those had gross residual disease far from 1cm of rectal wall. All patients underwent surgery within 4-8 week after completion of neoadjuvant therapy. In the control group which were not randomized, twenty-eight patients underwent neoadjuvant chemoradiation (45Gy in 25 Fraction with concurrent capecitabine 800mg/m2 twice daily for 5 days per week) followed by surgery. It was found that in HDR-BT group pathologic complete response (pCR), pathologic partial response (pPR) and pathologic response rates (pCR+pPR) based on AJCC TNM staging for colorectal cancer were %35.7, %35.7, and %71.4 respectively. The pCR, pPR, and pRR were %25, %17, and %42 in the control group respectively. pCR, pPR, and pRR were improved with HDR-BT. However, only response rate improvement was statistically significant (p=0.031). There was no a statistically significant difference in the complications between the two groups (p > 0.05). So it can be concluded that HDR intraluminal with or without interstitial brachytherapy may be an effective method of dose escalation technique in neoadjuvant chemoradiation therapy of locally advanced rectal cancer with higher response rate and manageable side effects.
The EMBRACE protocol involves a prospective multicenter study evaluating image-guided radiotherapy for cervical cancer, with a focus on improving outcomes. Key aspects of the protocol include:
1. Retrospective studies identified the benefits of MRI-based adaptive brachytherapy and established guidelines for parameters to evaluate.
2. The prospective EMBRACE I study involved over 1400 patients treated with chemoradiation followed by MRI-guided brachytherapy at 23 centers. Early results showed high local control rates and the benefits of combined intracavitary/interstitial brachytherapy in reducing morbidity.
3. The ongoing EMBRACE II study aims to further improve outcomes through
Reirradiation can provide local tumor control for recurrent head and neck cancer when surgery is not possible. Modern radiation techniques like IMRT allow higher radiation doses to be safely delivered to the tumor while minimizing risks of severe toxicity. Outcomes from reirradiation include a median survival of 10-12 months and 2-year local control rates of 40-64%. Patient selection is important to balance potential benefits of local tumor control against risks of treatment-related side effects.
This document describes a case study of a patient treated with mould brachytherapy for carcinoma of the lower lip. Custom moulds were made to deliver high dose rate brachytherapy in 15 fractions over 3 weeks. Planning using CT imaging and an Oncentra system optimized the dose distribution. The total dose was less than 100 Gy to minimize late toxicities. The patient experienced grade 3 mucositis that healed in 6 weeks with no evidence of recurrence at 9 month follow up, demonstrating mould brachytherapy can achieve local control in early stage oral cancers while preserving organ function.
Similar to Dosimetric evaluation of carcinoma nasopharynx using Volumetric Modulated Arc Therapy (VMAT): An institutional experience from Western India (20)
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
The biomechanics of running involves the study of the mechanical principles underlying running movements. It includes the analysis of the running gait cycle, which consists of the stance phase (foot contact to push-off) and the swing phase (foot lift-off to next contact). Key aspects include kinematics (joint angles and movements, stride length and frequency) and kinetics (forces involved in running, including ground reaction and muscle forces). Understanding these factors helps in improving running performance, optimizing technique, and preventing injuries.
Congestive Heart failure is caused by low cardiac output and high sympathetic discharge. Diuretics reduce preload, ACE inhibitors lower afterload, beta blockers reduce sympathetic activity, and digitalis has inotropic effects. Newer medications target vasodilation and myosin activation to improve heart efficiency while lowering energy requirements. Combination therapy, following an assessment of cardiac function and volume status, is the most effective strategy to heart failure care.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
District Residency Programme (DRP) for PGs in India.pptx
Dosimetric evaluation of carcinoma nasopharynx using Volumetric Modulated Arc Therapy (VMAT): An institutional experience from Western India
1. International Multispecialty Journal of Health (IMJH) ISSN: [2395-6291] [Vol-3, Issue-9, September- 2017]
Page | 332
Dosimetric evaluation of carcinoma nasopharynx using
Volumetric Modulated Arc Therapy (VMAT): An institutional
experience from Western India
Dr. Upendra Nandwana1§
, Dr. Shuchita Pathak2
, Dr. TP Soni3
, T Natarajan4
,
Venugopal5
, Umra Fatima6
, Jeevraj7
1
Senior Resident, Department of Radiation Oncology, Bhagwan Mahaveer Cancer Hospital and Research Centre,
Jaipur (Rajasthan) India
2
DNB Resident, Department of Radiation Oncology, Bhagwan Mahaveer Cancer Hospital and Research Centre,
Jaipur (Rajasthan) India
3
Consultant, Department of Radiation Oncology, Bhagwan Mahaveer Cancer Hospital and Research Centre,
Jaipur (Rajasthan) India
4-7
Medical Physicist, Department of Radiation Oncology, Bhagwan Mahaveer Cancer Hospital and Research Centre,
Jaipur (Rajasthan) India
Abstract— Treatment of nasopharyngeal carcinoma is done by advanced radiotherapy techniques like
VMAT (Volumetric Modulated Arc Therapy) where dose to critical organs around tumour is of
concern. Present study aimed to describe radiation dose to critical organs in nasopharyngeal cancer
patients using VMAT technique. Study was conducted on 10 carcinoma nasopharynx patients treated by
VMAT technique at a super-specialty cancer institute in Rajasthan. The structures were contoured
using RTOG (Radiation Therapy Oncology Group) guidelines and dose prescription to PTV (Planning
Target Volume) was such that 95% iso-dose covered 100% of PTV. Constraints to the OARs (Organs at
risk) were as per QUANTEC (Quantitative Analysis of Normal Tissue Effects in the Clinic). VMAT
planning was done by double arc using Eclipse (v 10.0.42) treatment planning system. Mean dose to
brain stem, spinal cord and optic chiasma were 51.79 Gy, 45.92 Gy and 18.8 Gy respectively. Mean
dose to left and right temporal lobes was 22.7Gy and 24.3Gy. Dose to right and left eye were 20.6 Gy
and 19.2 Gy while dose to right and left lenses were 5.9Gy and 5.8 Gy respectively. Dose to brain stem,
spinal cord, optic chiasma, eyes, lens and temporal lobes were below the dose constraints. VMAT is an
effective way to deliver maximum radiation to tumour tissue while providing better sparing of normal
tissue and less doses to OARs in carcinoma nasopharynx.
Keywords: Nasopharyngeal carcinoma (NPC), Volumetric Modulated Arc Therapy, Radiation
Therapy Oncology Group.
I. INTRODUCTION
Nasopharyngeal carcinoma (NPC) is endemic in Southeast Asia region. Radiation therapy has been the
mainstay treatment of patients of nasopharyneal carcinoma. It is a curative treatment for many patients
with non metastatic NPC. It is a radiosensitive tumour but it needs complex treatment plan due to its
irregular concave shape, location and close proximity of tumour to the critical organs like spinal cord,
brain stem, salivary glands, eyes, optic nerves etc.1
In past decade significant progress has been made in field of radiotherapy delivery.1
. IMRT can provide
precise dose distribution in three dimensions. IMRT presents more conformity for irregular target
volumes close to critical organs and provides better tumor control and reduces radiation dose to nearby
normal tissue. IMRT provides better therapeutic ratio by maximizing dose to the tumour while sparing
normal tissue.2,3
In NPC, IMRT provides better dose distribution to the target volume while lower dose
to the OARs (Organs at risk).4,5
The delivery of IMRT is by a set of fixed radiation beams shaped using
2. International Multispecialty Journal of Health (IMJH) ISSN: [2395-6291] [Vol-3, Issue-9, September- 2017]
Page | 333
the projection of the target volume. Volumetric Modulated Arc Therapy (VMAT) is another advance in
the field of radiotherapy. It is a technique in which IMRT is given in an arc based manner with
simultaneously changing multi leaf collimator (MLC) position, gantry position, and dose rate.
This concept has been clinically used in the Eclipse treatment planning software under the name Rapid
Arc (RA).
Conventional IMRT delivers fully intensity-modulated radiotherapy fields with a multi leaf collimator
(MLC) from a finite number of fixed gantry angles, while RA delivers radiotherapy with MLC that
changes the shape of the treatment field dynamically while the gantry rotates around the patient. The
purpose of this study was to describe the dose to critical organs in nasopharynx using VMAT
technique.
II. METHODOLOGY
A dosimetric study was conducted using medical records of ten patients of nasopharyngeal cancer who
were treated with curative intent between January to July 2017. All patients underwent pretreatment
evaluation including clinical examination, imaging (MRI/CT) and pretreatment biopsy proof was done.
The tumours were staged according to the American Joint Committee on Cancer Staging System. All
patients received concurrent chemo-radiotherapy. Radiotherapy was delivered using VMAT technique
(rapid arc).VMAT plans of these ten patients were evaluated. Six out of ten patients had advanced
clinical stages (stage III/IV)
2.1 Radiotherapy
First of all planning CT scan was done with 5 clamp thermoplastic head and neck or fit with a slice
thickness of 3mm, from vertex to below the level of clavicles. Images were then transferred to
contouring workstations for contouring of target volumes and critical normal structures. Radiotherapy
was delivered with a 6MV linear accelerator using a dynamic multi leaf collimator.
The structures were contoured as per RTOG (Radiation Therapy Oncology Group) guidelines and the
dose prescription to PTV (Planning Target Volume) was such that 95% iso-dose covered 100% of the
PTV. Gross tumour volume (GTV70) included the primary tumour and any clinically involved lymph
node, taking into consideration, physical examination, nasopharyngoscopy findings, CT, PET-CT and
MRI. The clinical target volume (CTV70) was created from GTV70 by creating 0.5-1.0 cm margins.
The planning target volume (PTV70) was created from CTV by creating 5 mm margin. The CTV 54
included the entire Nasopharynx, posterior ethmoids, posterior third of nasal cavity and maxillary
sinuses, inferior sphenoid sinuses, clivus, cavernous sinuses and elective nodal areas. Neck lymph nodes
level II-IV was included in CTV54 in all cases. Dose prescription was given according to the ICRU 50
(International Commission on Radiation units and Measurements) recommendations.
Spinal cord, brain stem, optic chiasma, bilateral parotid, eyes, lens and temporal lobes were contoured
as OAR. Constraints to the OARs were as per QUANTEC (Quantitative Analysis of Normal Tissue
Effects in the Clinic). According to this, maximum dose to spinal cord and brain stem should be less
than 45 Gy and 54 Gy respectively. At least one parotid gland mean dose should be less than 26 Gy or
volume receiving 30 Gy radiations should be less than 50% of the parotid volume. The planning of all
patients was done by double arc using Eclipse treatment planning system. The dose to the critical organs
was deduced from the dose volume histogram (DVH).
Table 1 shows the dose limits for OARs.
3. International Multispecialty Journal of Health (IMJH) ISSN: [2395-6291] [Vol-3, Issue-9, September- 2017]
Page | 334
Table 1
Dose Constraints for OARs and End Points for Nasopharyngeal Carcinoma
Structure End point Dose (Gy) Planning Aim
Brain stem Necrosis 54 1% of the PRV should not exceed 60Gy
Brain Necrosis 60 1% of the normal brain should not exceed 60Gy
Chiasm Blindness 60 0.03cc of the chiasm should not exceed 60Gy
Spinal cord Myelitis 45 or 1cc of PRV should not exceed 50Gy
Eyes Blindness 50 Mean dose less than 50Gy
Lens Cataract 10 As low as possible
Optic nerves Blindness 54 0.03 cc should not exceed 54Gy
Mandibles Osteoradio -necrosis 70 1% of the mandible should not exceed 70Gy
Parotids Xerostomia 26 Mean dose ≤26Gy D50 should be ≤ 30 Gy for one gland
Oral Cavity
(excluding PTV)
late mucosal necrosis 40 Mean dose less than 40Gy
Unspecified Tissue 72 1cc of normal tissue outside the PTV should not receive d
not receive ≥ 110 % of PTV
*PTV-Planning Target Volume; *PRV-Planning Risk Volume; RTOG Protocol 0225
2.2 VMAT plan
Varian Rapid Arc linear accelerator, equipped with a millennium MLC with 120 leaves, was used for
treatment. Six MV photon beams were applied to treatment plans with a maximum dose rate of
600MU/min. As a part of inverse planning, the optimization process was done using PRO algorithm
(Progressive resolutive optimization).
III. RESULT
The critical structures contoured were the parotids, brain stem, spinal cord, temporal lobes, eyes, lens,
optic chiasma and optic nerves. The mean dose to the left and right parotids were 33.7 Gy and 31.4 Gy
respectively, while dose to the brain stem, spinal cord and optic chiasma were 51.79 Gy, 45.92 Gy and
18.8 Gy respectively. The mean dose to the left and right temporal lobes was 22.7Gy and 24.3Gy
respectively. The dose to right and left eye were 20.6 Gy and 19.2 Gy respectively, while dose to right
and left lenses were 5.9Gy and 5.8 Gy respectively. The dose to brain stem, spinal cord, optic chiasma,
eyes, lens and temporal lobes were below the dose constraints while the dose to parotids were above the
dose constraints probably because most (six out of ten) of these patients were advanced cases. Doses to
OARs are presented in Table 2.
Table 2
Details of dose to the organs at risk (OARs)
S. No. Organ at Risk VMAT (Gy)
1 Spinal chord Max 45.92
2 Brain stem Max 51.79
3 Parotid
R mean 33.7
L mean 31.4
4 Eye
R max 20.6
L max 19.2
5 Lens
R max 5.9
L max 5.8
6 Optic chiasm Max 18.8
7 Optic nerves
R max 28.4
L max 27
8 Temporal lobe
R mean 24.3
L mean 22.7
4. International Multispecialty Journal of Health (IMJH) ISSN: [2395-6291] [Vol-3, Issue-9, September- 2017]
Page | 335
IV. DISCUSSION
Radiotherapy plays an important role in local nasopharyngeal treatment. NPC patients have better
outcomes and life expectancy than other head and neck cancers. Five year survival reaches upto 85% in
early stage disease.6-8
Important point to be considered while planning for NPC is sparing of OARs as
many critical structures are in proximity to this three dimensional irregular concave shape tumour.
Advances in planning and implementation of RT have focused on delivering max dose to tumour while
sparing of surrounding critical structure. VMAT is a novel IMRT technology that has the potential of
fulfilling this aim. It allows dose rate, gantry rotation and MLC fiber velocity to be varied during
treatment.9
There are few past studies that have compared the dosimetry analysis between VMAT and IMRT in
head and neck cancer including NPC.10-12
Vanetti et al13
in a study showed that VMAT provided a better
sparing effect to OARs compared to conventional fixed field IMRT with similar target coverage in head
and neck cancers. VMAT reduced the mean dose to the contralateral parotid gland by 13.5% while the
decrement of maximal doses to the spinal cord and brain stem were 8.9% and 35.1%, respectively. In
present study VMAT was able to achieve dose limits of all OARs except for parotids. In parotid dose
limit could not be achieved due to advanced stage (III and IV) in these cases which caused close
proximity of tumour volume to parotids.
Results of present study are concordant with those presented by Zheng et al,14
where in a study of 20
patients of stage III and IV, mean dose radiation in left and right parotid was recorded to be 32.9Gy and
33.4Gy respectively. Similarly in present study the mean dose of right and left parotid were 33.7 and
31.4Gy respectively.
Limitation of present study includes smaller number of patients and difference in the patient tumour
volumes.
V. CONCLUSION
Present study supports VMAT as an effective way to deliver maximum radiation to tumour tissue while
providing better sparing of normal tissue and less doses to OARs in carcinoma nasopharynx. Further
studies with larger sample size and prospective design are required to firmly establish VMAT and its
further enhancement.
CONFLICT OF INTEREST
None declared till now.
ACKNOWLEDGEMENT
We would like to thank all the teachers of radiation oncology department and medical physicists
including T Senthil, Rajkamal and Ratish for providing their valuable support and help.
REFERENCES
[1]. Hong TS, Ritter MA, Tome WA, Harari PM. Intensity-modulated radiation therapy: emerging cancer treatment
technology.Br J Cancer 2005;92:1819-1824.
[2]. Kam MK, Chau RM, Suen J, Choi PH, Teo PM. Intensity-modulated radiotherapy in nasopharyngeal carcinoma:
dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 2003;
56:145-157.
5. International Multispecialty Journal of Health (IMJH) ISSN: [2395-6291] [Vol-3, Issue-9, September- 2017]
Page | 336
[3]. Scott-Brown M, Miah A, Harrington K, Nutting C. Evidence- based review:quality of life following head and neck
intensity-modulated radiotherapy. Radiother Oncol 2010;97:249-257.
[4]. Chau RM, Teo PM, Kam MK et al. Dosimetric comparison between 2-dimensional radiation therapy andintensity
modulated radiation therapy in the treatmentof advanced T-stage nasopharyngeal carcinoma: to treat less or more in the
planning organ-at-risk volume of the brainstem and spinal cord. Med Dosim 2007;32:263-270.
[5]. Wu Q, Manning M, Schmidt-Ullrich R et al. The potential for sparing of parotids and escalation of biologically
effective dose with intensity-modulated radiation treatments of head-and-neck cancers: a treatment design study. Int J
Radiat Oncol Biol Phys 2000;46:195-205.
[6]. Xiao WW, Han F, Lu TX, Chen CY, Huang Y, Zhao C. Treatment outcomes after radiotherapy alone for patients with
early-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2009;74:1070-1076.
[7]. Yi JL, Gao L, Huang XD et al. Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of
a single institution. Int J Radiat Oncol Biol Phys 2006;65:161-168.
[8]. Zhao C, Han F, Lu LX et al. Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma.
Ai Zheng 2004;23:1532-1537.
[9]. Palma D, Vollans E, James K et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison
with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys
2008;72:996-1001.
[10]. Verbakel WF, Cuijpers JP, Hoffmans D, Bieker M, Slotman BJ, Senan S.Volumetric intensity-modulated arc therapy
vs. conventional IMRT in head and neck cancer: a comparative planning and dosimetric study. Int J Radiat Oncol Biol
Phys 2009;74:252-259.
[11]. Bertelsen A, Hansen CR, Johansen J, Brink C. Single arc volumetric modulated arc therapy of head and neck cancer.
Radiother Oncol 2010;95:142-148.
[12]. Johnston M, Clifford S, Bromley R, Back M, Oliver L, Eade T. Volumetric modulated arc therapy in head and neck
radiotherapy: a planning comparison using simultaneous integrated boost for nasopharynx and oropharynx carcinoma.
Clin Oncol (R Coll Radiol) 2011;23:503-511.
[13]. Vanetti E, Clivio A, Nicolini G et al. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-
pharynx and larynx: a treatment planning comparison with fixed field IMRT. Radiother Oncol 2009;92:111-117.
[14]. Zheng, et al. Dosimetry comparison between volumetric modulated arc therapy with rapidarc and fixed field dynamic
IMRT for local-regionally advanced nasopharyngeal carcinoma. Chin J Cancer Res. 2011;23(4):259–64.